ABSTRACT

The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment o

chapter 9|20 pages

Alfuzosin A Jardin

chapter 10|28 pages

Tamsulosin